As FDA shortages lift, patients and physicians explore new options for continued treatment with compounded GLP-1 medications.

Compounding pharmacy FarmaKeio NM is cementing its role as a crucial part of Winrock Town Center’s developing wellness sector ...

For decades, the United States has led the world in pharmaceutical innovation — developing drugs that combat cancer, heart ...

A rise in the use of non-FDA-approved diabetes and obesity medications has spurred health care professionals and medical ...

Colonel Jeffrey D. Glover and Dr. Benjamin F. Chavis Jr. The new FDA-approved weight loss medicines have changed the game for people with obesity, offering millions of Americans a chance to transform ...

For Maria Rising, managing her health felt like chasing a phantom. The 30-year-old Lansing, Mich. consultant has for years ...

A Plano pharmacist billed federal and private payers for hundreds of millions while paying out millions in kickbacks to ...

Hims & Hers Health (NYSE:HIMS) shares were on a massive run, but that momentum hit a wall recently. Since its peak on ...

Wegovy contains the same main ingredient as Ozempic, semaglutide, and is FDA-approved for weight loss in people with obesity or who are overweight with at least one weight-related condition. It is ...

Tirzepatide — a drug that acts both as a GLP-1 agonist and a GIP agonist — is the active ingredient in an even more powerful ...

Compounded GLP-1s have given rise to a cottage industry offering cheaper weight loss medications to many Americans — but now ...

Now that the shortage of semaglutide injection products has been resolved, the Food and Drug Administration (FDA) will restrict third parties ...